Evaluation of the Right Ventricle Using Echocardiography

The right ventricle’s thin walls, crescentic shape, and complex three-part anatomy (inlet, trabeculated apex, and outflow tract) make it inherently harder to image and quantify than the left ventricle — no single 2D geometric model captures all three components at once. Despite this, RV assessment is essential for diagnosing and managing pulmonary hypertension, heart failure, and right-sided valve disease. This tutorial covers RV size, systolic and diastolic function, and a full noninvasive hemodynamic assessment, drawing primarily on the 2025 ASE right heart and pulmonary hypertension guideline — an explicit replacement for the widely-used 2010 ASE guideline, with updated normative values based on much larger contemporary reference datasets — alongside foundational anatomic and physiologic material from ASE Comprehensive Echocardiography and the 2020 BSE right heart guideline.

Why the RV Behaves Differently: Anatomy and Physiology That Explain the Rest of This Page

A few structural facts explain why RV assessment technique, and RV pathophysiology, genuinely differ from the LV rather than simply being a smaller version of it.

• Myofiber architecture: the RV has a circumferential arrangement of myofibers in the subepicardium and a longitudinal arrangement in the subendocardium. This is precisely why longitudinal parameters (TAPSE, S′) are such sensitive markers of RV systolic function — they’re measuring the dominant fiber direction directly.
• Coronary supply is distinct from the LV in a clinically important way. The right coronary artery (RCA) provides the predominant flow to the RV, supplying the lateral wall via acute marginal branches and the posterior wall and posterior interventricular septum via the posterior descending artery; the anterior wall is supplied by the conus artery (an RCA branch) and LAD branches. RV coronary flow occurs during both systole and diastole — unlike the LV, where flow is predominantly diastolic. The clinical correlation is direct: the more proximal the RCA occlusion, the more extensive the RV infarction. A genuinely practical consequence: with a distal RCA occlusion, the lateral RV free wall (seen on the standard apical four-chamber view) may contract normally while only the inferior/diaphragmatic wall is akinetic — if the subcostal view is skipped, this distal-occlusion RV infarction can be missed entirely, since it’s the view that specifically shows the diaphragmatic surface.
• Why the RV is disproportionately afterload-sensitive. Two mechanisms: first, RV coronary flow is more vulnerable to pressure elevation, so an acute afterload rise can itself provoke RV ischemia. Second, by Laplace’s law, wall stress is inversely proportional to wall thickness — and because the RV wall is thin, wall stress rises much faster with a given pressure increase than it would in the thick-walled LV. This is the mechanistic reason a normally-functioning RV tolerates a slowly rising afterload reasonably well but decompensates rapidly with an abrupt one.
• A specific example of this vulnerability: acute pulmonary embolism. RV coronary flow, being systolic-dominant (the opposite of the LV), makes the RV midwall specifically susceptible to ischemia when an abrupt PA pressure rise increases myocardial oxygen demand while simultaneously impairing coronary perfusion at that same location — a proposed mechanism behind the segmental midwall dysfunction that’s a recognized echocardiographic feature of major PE.
• The RV is nonetheless remarkably adaptable. Resting peak systolic RV pressure is normally under 30 mmHg, but with exercise this can rise to 40 mmHg in unconditioned healthy adults and as high as 55 mmHg in athletes or those over 65 — a slow, graded rise through increasing workload is the normal pattern, while a rapid pressure rise is more characteristic of a pathologic response. Under the right circumstances the RV can even sustain a systemic circulatory role over decades, as seen in congenitally corrected transposition — see Congenitally Corrected Transposition for that anatomy.

The RV-Focused View

Before any measurement technique, the imaging window itself matters. Starting from the standard apical four-chamber view, sliding the transducer laterally — while keeping the LV apex centered at the top of the sector and avoiding the LV outflow tract coming into view — brings the entire RV free wall into view along with its true maximal long-axis dimension. This RV-focused view gives meaningfully more reproducible RV size and function measurements than the conventional four-chamber window, and should be the standard for all apically acquired RV metrics discussed below.

A complete RV structural exam is genuinely multi-view, since no single plane shows every wall: parasternal long-axis shows the RVOT; parasternal short-axis shows the anterior, lateral, and inferior free walls; the RV inflow view shows the anterior and inferior free walls; the (RV-focused) apical four-chamber shows the lateral free wall and apex; and the subcostal four-chamber view shows the inferior/diaphragmatic wall specifically — the view most likely to be skipped, and, as above, the one whose omission can miss a distal RCA-territory RV infarction.

Recognized Limitations of 2D RV Assessment

Worth stating plainly rather than discovering mid-study: the RV’s anterior retrosternal position, complex asymmetric shape, heavily trabeculated endocardial border, the need for separate views to see the inflow and outflow portions, asymmetric distribution of RV mass, and genuine load dependency of every function parameter are all real, structural limitations of 2D assessment — not signs that a study has been performed poorly.

RV Size

Dimensions

Qualitatively, the RV should appear no larger than about two-thirds the size of the LV in the apical four-chamber view, with the LV apex still forming the true cardiac apex. Quantitatively, current guidelines give overlapping but not identical normal ranges — worth knowing both exist:

Parameter	ASE 2025 (both sexes, normal)	BSE 2020 (sex-specific, normal)
RV basal diameter	< 4.1 cm	≤ 4.7 cm (M) / ≤ 4.3 cm (F)
RV mid-cavity diameter	< 3.5 cm	≤ 4.2 cm (M) / ≤ 3.5 cm (F)
RV longitudinal dimension	< 8.2 cm	≤ 8.7 cm (M) / ≤ 8.0 cm (F)
RV wall thickness	< 0.5 cm	< 0.5 cm

The ASE 2025 figures come from a large, contemporary meta-analysis and are given as single normal thresholds rather than split by sex; the BSE protocol instead applies sex-specific cutoffs derived from a separate reference dataset. Both are reasonable, current sources — if your lab follows one guideline consistently, use its figures, rather than mixing cutoffs from different sources within the same report.

RV basal diameter is measured at end-diastole, just beneath and parallel to the tricuspid annular plane; the mid-cavity dimension roughly halfway between the annulus and apex; the longitudinal dimension from the annular midpoint to the true apex (adjusted for any leftward apical displacement, to avoid foreshortening). RV wall thickness is preferentially measured from the subcostal view at end-diastole, at the RV inflow segment, excluding trabeculations and papillary muscle — a value above 5 mm indicates RV hypertrophy, though this is a nonspecific finding seen across pressure-overload states and infiltrative or inherited cardiomyopathies alike.

A useful qualitative chamber-ratio pattern in chronic pressure overload (cor pulmonale): normal RV/LV and RA/LA ratios both run under 1 (RV and RA each smaller than their left-sided counterparts); with chronic pressure overload, this reverses — RV/LV and RA/LA ratios both rise above 1, a simple, visually recognizable pattern of “the right side has caught up with, or exceeded, the left.”

Right Atrial Size

The right atrium is frequently under-assessed, but RA size carries real prognostic weight — each 1 cm² increase in RA area has been associated with a measurable increase in morbidity risk in pulmonary hypertension. Because a standardized biplane approach isn’t available for the RA the way it is for the LV, the single-plane method of discs, from a dedicated RA-focused view, is the recommended volumetric method. Normal thresholds: RA area < 19 cm², RA volume index by method of discs < 30 mL/m². Note that RA size can be enlarged in otherwise healthy individuals — athletes and men in particular — even after indexing to body surface area, so an enlarged RA should prompt a look for supporting evidence (impaired RA function, significant TR, or signs of elevated RA pressure) before being called clinically abnormal. See the Evaluation of the Right Atrium tutorial for RA anatomy, phasic function, and strain in full.

RV Systolic Function

No single RV systolic function parameter is fully load-independent, and each captures only part of the RV’s contraction pattern (longitudinal, radial, or global). Current guidance is explicit: report at least one longitudinal parameter (TAPSE or S′) alongside a measure or qualitative statement of radial function (FAC), since TAPSE and S′ only reflect the basal, longitudinal component and can look reassuring even when overall RV function is genuinely impaired — a particular risk in pressure-overload states like pulmonary hypertension, where radial contraction is often more representative of true global function.

TAPSE

Tricuspid annular plane systolic excursion measures the longitudinal excursion of the lateral tricuspid annulus during systole, using an M-mode cursor aligned from the RV-focused view.

Normal	Mild	Moderate	Severe
> 1.7 cm	1.3–1.7 cm	1.0–1.3 cm	≤ 1.0 cm

TAPSE is simple to obtain and has the most abundant reference data of any RV systolic parameter, but it has real limitations: it’s angle-dependent, reflects only the basal free wall segment (not the apex or outflow tract), and can be falsely reassuring after cardiothoracic surgery or when the RV exhibits a “rocking” translational motion rather than true contraction (as can occur in pulmonary hypertension).

Tissue Doppler S′ Velocity

The peak systolic annular velocity, measured by pulsed-wave tissue Doppler at the lateral tricuspid annulus, with the beam kept within about 20° of the annular motion to limit angle-dependent error.

Normal	Mild	Moderate	Severe
> 9.5 cm/s	7.2–9.5 cm/s	5.0–7.2 cm/s	≤ 5.0 cm/s

S′ is closely correlated with TAPSE — the two should generally agree if both are measured correctly — and shares the same core limitation: it reflects only the basal free wall, not the ventricle as a whole.

Fractional Area Change (FAC)

FAC traces the RV endocardial border (including trabeculations and the moderator band) at end-diastole and end-systole from the RV-focused view, and calculates the percentage area change:

FAC (%) = [(RVEDA − RVESA) ÷ RVEDA] × 100

Normal	Mild	Moderate	Severe
> 35%	29–35%	22–29%	≤ 22%

Unlike TAPSE and S′, FAC captures both longitudinal shortening and radial thickening, plus the interventricular septum’s contribution — which is exactly why it’s recommended as the companion measure to a longitudinal parameter. Its main limitation is that it doesn’t include the RV outflow tract, which can matter in specific populations (repaired tetralogy of Fallot, for instance, where alternative measures may be more reliable). If RV visualization is suboptimal despite optimization, ultrasound-enhancing agents can improve endocardial border delineation — and when they’re already being used for LV opacification, it’s worth simply including RV imaging in that same protocol rather than as an afterthought.

RVOT Velocity-Time Integral and Acceleration Time

A genuinely underused pair of parameters, both obtained by PW Doppler in the RVOT from the parasternal short-axis view at the aortic valve level, tilted superiorly, with the sample volume placed 1–2 mm just beneath the pulmonic valve.

• RVOT VTI is used to calculate RV stroke volume (RV SV = π × (RVOT diameter ÷ 2)² × RVOT VTI) and, on its own, a value over 18 cm is normal.
• RVOT acceleration time (AccT), measured from the onset of flow to peak pulmonary velocity on that same signal, is normal above 105 ms — though it’s less reliable at heart rates under 60 or over 100 bpm, and shouldn’t be used alone.
• The shape of the RVOT VTI Doppler envelope is itself a genuinely useful, independent signal of advancing pulmonary vascular disease and rising PVR — worth learning to recognize by eye:
  • Normal: a smooth, parabolic contour peaking in mid-systole, reflecting a compliant, low-resistance pulmonary bed.
  • Rising PVR: the contour becomes more triangular, with an earlier systolic peak.
  • Increasing impedance: a mid-systolic notch appears — the “W sign.”
  • Advanced PH: the contour becomes frankly spiked, with early ejection and a reduced signal envelope, reflecting rapid RV-PA pressure equilibration from severely reduced PA compliance.
• The RVOT VTI/PASP ratio has also been studied as an alternative RV-PA coupling numerator, correlating with invasive PA compliance and helping discriminate precapillary from postcapillary PH related to HFpEF — though more validation data are still needed before routine use.

RV dP/dt

The instantaneous rate of RV pressure rise, estimated from the ascending limb of the CW Doppler TR signal (at a 200 mm/s sweep speed) as the time interval over which TR velocity rises from 1 to 2 m/s — a value under 400 mmHg/s is abnormal. This is a validated surrogate for global RV contractility, but the guideline is explicit that, given a lack of normative data, it should be considered adjunctive rather than used in routine practice.

3D Ejection Fraction

Where image quality and equipment allow, 3D echocardiography avoids the geometric assumptions inherent to 2D area- or length-based methods entirely.

Normal	Mild	Moderate	Severe
> 45%	39–45%	32–39%	< 32%

3D RV volumes tend to run somewhat smaller than cardiac MRI, the reference standard, particularly with older multi-beat acquisition techniques; more contemporary single-heartbeat full-volume acquisition reduces this gap. 3D assessment also requires real acquisition and analysis experience to apply reliably.

RV Strain

Speckle-tracking-derived RV longitudinal strain comes in two distinct forms that shouldn’t be used interchangeably:

• RV free wall strain (RVFWS) — three segments (basal, mid, apical), free wall only — normal more negative than −20%
• RV global longitudinal strain (RVGLS) — six segments, adding the interventricular septum — normal more negative than −17%

RVFWS is generally considered the more accurate reflection of intrinsic RV contractility specifically, since it isolates the RV free wall from the septum’s shared contribution with the LV. Both are sensitive enough to detect subclinical RV dysfunction that conventional measures still call normal, but inter-vendor software differences remain a real limitation — serial measurements in the same patient should use the same vendor platform for a meaningful comparison.

Myocardial Performance Index (MPI / Tei Index)

A load-sensitive but practical index of combined systolic and diastolic performance, obtainable by either pulsed-wave Doppler or tissue Doppler (the two methods give different values and shouldn’t be used interchangeably within the same series). It can be calculated either of two equivalent ways:

MPI = (IVRT + IVCT) ÷ ET, or MPI = (TCO − ET) ÷ ET

where IVCT is the interval from tricuspid closure to pulmonic opening, ET is RV ejection time (pulmonic opening to closure), IVRT is pulmonic closure to tricuspid opening, and TCO (tricuspid closure-to-opening) is the sum of all three. Because the RVOT and tricuspid inflow measurements come from different images, using beats with similar R-R intervals improves accuracy.

• Normal: < 0.40 by pulsed-wave Doppler, < 0.55 by tissue Doppler

MPI’s real advantage is that it doesn’t depend on RV geometry at all — a genuine strength given how hard RV geometry is to model — but it’s sensitive to loading conditions and can pseudo-normalize when RA pressure is elevated (since a high RA pressure opens the tricuspid valve earlier, shortening isovolumic relaxation time and underestimating the index).

RV-PA Coupling

RV-PA coupling describes how well RV contractility is matching its pulmonary afterload — a genuinely different question from either RV function or pulmonary pressure viewed in isolation. The most widely used non-invasive surrogate is the TAPSE/PASP ratio, validated against invasive pressure-volume measurement.

• A healthy TAPSE/PASP ratio generally falls around 0.5–0.7 mm/mmHg
• A ratio in the range of 0.3–0.4 mm/mmHg is associated with RV-PA uncoupling and a meaningfully increased mortality risk, validated across pre- and post-capillary pulmonary hypertension and heart failure populations

This matters clinically because TAPSE alone tends to decline early in RV remodeling but can plateau in more advanced disease — meaning TAPSE by itself has limited ability to distinguish adaptive from maladaptive remodeling. Integrating it with afterload (via PASP) captures something a longitudinal function measure alone cannot. FAC/PASP and RVFWS/PASP ratios have also been studied and may outperform TAPSE/PASP in some populations, though TAPSE/PASP remains the most widely validated and used in practice.

RV Adaptive vs. Maladaptive Remodeling

Right heart adaptation to increased afterload is the single main determinant of morbidity and mortality in pulmonary hypertension, and it progresses along a recognizable continuum rather than jumping straight from normal to failing:

1. Adaptive remodeling: concentric RV hypertrophy (increased wall thickness) develops to maintain contractile force and cardiac output against the rising afterload, with minimal chamber dilation and preserved function.
2. Transitional remodeling: the contractile increase becomes insufficient to maintain output, so the chamber begins to dilate to preserve stroke volume instead. A specific, recognizable sign appears at this stage: apical tracking — leftward tethering of the RV apex, reflecting weakening RV function’s inability to counterbalance LV forces any longer.
3. Maladaptive remodeling: right heart chamber sizes increase further, RV systolic dysfunction and an abnormal LV eccentricity index develop, and the ventricle progresses to overt RV-PA uncoupling — with tricuspid annular dilation and functional TR frequently emerging at this stage.

A comprehensive assessment integrating structural change (size, hypertrophy, apical tracking) with functional measures (TAPSE/PASP coupling especially) is what’s recommended to systematically place a given patient along this continuum, rather than relying on any single snapshot measurement.

Distinguishing PH Phenotypes by Echo Pattern

Definitive classification of pulmonary hypertension still requires invasive right heart catheterization, but the echocardiographic phenotype often points clearly toward one WSPH group over another:

Feature	Group 1 (precapillary PAH)	Group 2 (postcapillary, left heart)	Group 3 (lung disease, precapillary)
Left heart	Normal or small	LVH and/or dilated, dilated LA	Variable — shared risk factors with Group 2
Mitral E/e′	Normal (< 8)	Elevated (> 14)	Normal, unless concomitant Group 2 disease
Right heart	Dilated (RV/LV > 1), RA ≥ 19 cm², RVH	Normal until late in the disease course	Normal or small, with RVH, until late
LV eccentricity index	> 1.1	Normal (< 1.2)	Variable
LV diastolic function	—	Usually ≥ Grade 2 dysfunction	Usually ≥ Grade 1 dysfunction
Valve disease	—	Often ≥ mild-moderate mitral or aortic disease	—
Typical patient	Younger, fewer cardiovascular comorbidities	Older, more cardiovascular comorbidities	Variable; difficult acoustic windows — use subcostal views

Peak TR velocity ≥2.9 m/s is seen in both Group 1 and Group 2 disease — it confirms elevated pulmonary pressure but doesn’t by itself distinguish the cause, which is exactly why the surrounding left-heart and diastolic-function findings carry the real discriminating weight in this table.

RV Diastolic Function

RV diastolic assessment is less standardized than LV diastolic function and isn’t part of a routine study in most labs, but it’s a genuinely sensitive marker — RV diastolic dysfunction often precedes overt systolic dysfunction, dilation, or hypertrophy, particularly in pulmonary hypertension.

A correction worth making explicitly: normal RV E/A ratio is 0.8–2.1 — a considerably wider range than the roughly-1.0 cutoff that might be assumed by loose analogy with the LV. Below 0.8 suggests impaired relaxation; above 2.1 suggests restrictive filling. Both current guidelines (ASE 2025 and BSE 2020) agree on this range.

	Normal	Impaired relaxation	Pseudonormal	Restrictive
E/A ratio	0.8–2.1	< 0.8	0.8–2.1	> 2.1
Deceleration time	120–230 ms	> 230 ms	120–230 ms	< 120 ms (BSE: < 57 ms severe)
e′/a′ ratio	0.5–1.8	—	—	≥ 1.8
E/e′ ratio	< 6.0	—	—	≥ 6.0–8.5 depending on severity

As with LV diastolic assessment, no single parameter should be read in isolation — a pseudonormal E/A pattern looks identical to a normal one on transmitral inflow alone, and is only distinguished by the supporting parameters (tissue Doppler e′/a′ and E/e′, morphologic RA/RV/IVC assessment, and hepatic vein flow) around it. Hepatic vein flow is the RV-side analog of pulmonary vein flow on the left: normal shows systolic-predominant forward flow, and diastolic-predominant flow suggests elevated RA pressure — quantified more precisely below.

A Full Noninvasive Hemodynamic Assessment

Right Atrial Pressure: A Four-Tier Algorithm, Not Three

RAP is estimated from the IVC diameter, measured at end-expiration 0.5–3.0 cm proximal to the RA ostium (distal to the hepatic vein) from the subcostal view, together with its respirophasic collapse on sniff and quiet respiration. Report a specific numeric value, not a range, for standardization:

RAP	IVC diameter and collapse
3 mmHg (0–5)	≤ 2.1 cm and ≥ 50% collapse
8 mmHg (5–10) — indeterminate	≤ 2.1 cm and < 50% collapse, or > 2.1 cm and ≥ 50% collapse
15 mmHg (10–20)	> 2.1 cm and < 50% collapse
20 mmHg	> 2.5 cm and < 50% collapse, with dilated hepatic veins and spontaneous echo contrast or color flow reflux

For indeterminate cases, resolve using secondary indices rather than defaulting to 8 mmHg automatically: RA enlargement, interatrial septal bulging into the LA throughout the cycle, a restrictive right-sided diastolic filling pattern, tricuspid E/e′ > 6, or a hepatic vein systolic filling fraction under 55% [HVs ÷ (HVs + HVd)] — a sensitive and specific sign of elevated RAP in its own right. If none of these are present, downgrade to 3 mmHg; if present, upgrade to 15 mmHg; if genuine uncertainty remains, use 8 mmHg.

Special populations: IVC dilation can be a normal finding in healthy young adults, athletes, and pregnant women (from increased total blood volume) — look for corroborating evidence before calling it abnormal in these groups. In mechanically ventilated patients, hepatic vein velocities remain valid if averaged over at least five consecutive beats spanning at least one respiratory cycle, and an IVC diameter ≤2.1 cm in an intubated patient reliably identifies RAP under 10 mmHg.

RV Systolic Pressure

RVSP = 4 × (peak TR velocity)² + RAP, equivalent to PASP absent RVOT obstruction, pulmonic stenosis, or proximal PA obstruction. RVSP ≥ 35 mmHg is generally considered abnormal.

• Resting peak TRV ≥ 2.9 m/s (or ≥ 2.8 m/s with at least two adjunctive signs — RV enlargement, an abnormal septal eccentricity index, a short RVOT acceleration time, or signs of elevated RA pressure) suggests PH and warrants further evaluation.
• Averaging protocol: 3 consecutive beats in sinus rhythm; 5–10 beats in arrhythmia, from the same acoustic window. Never use the single highest velocity following a premature contraction or a pause.
• A practical Doppler technique tip, worth remembering as “chin, not beard”: measure the densest primary edge of the CW signal, not its faint outer envelope, optimizing gain and brightness across multiple imaging planes — agitated saline, blood-saline contrast, or an ultrasound-enhancing agent can augment a weak signal; overgaining should be avoided rather than compensated for by eye.
• The shape of the CW Doppler TR envelope itself affects accuracy when TR is significant: a triangular contour tends to underestimate RVSP, while a parabolic contour gives a more accurate estimate.
• Healthy physiologic aging and increasing body surface area can each modestly elevate RVSP without true PH being present — worth weighing before treating a borderline value as diagnostic on its own.

Pulmonary Artery End-Diastolic Pressure

A less commonly reported but genuinely useful parameter, obtained from the CW Doppler end-diastolic pulmonic regurgitation velocity:

PAEDP = 4 × (peak end-diastolic PR velocity)² + RAP

Obtained from the parasternal short-axis, PA-focused view, with the peak end-diastolic PR velocity measured at a sweep speed of 75–100 mm/s. A resting value ≥ 2.2 m/s is generally considered abnormal. Severe PR tends to underestimate PAEDP; constrictive or restrictive RV physiology, via a rapid diastolic deceleration slope, tends to overestimate it.

Mean Pulmonary Artery Pressure

Several formulas exist; the most common is:

mPAP = (1/3 × PASP) + (2/3 × PAEDP)

Alternatives include mPAP = 79 − (0.45 × RVOT AccT), mPAP = 90 − (0.62 × RVOT AccT) when AccT < 120 ms, mPAP = 4 × (early PR velocity)² + RAP, mPAP = VTI(TR) + RAP, and mPAP = (PASP × 0.61) + 2 mmHg. mPAP > 20 mmHg is abnormal — the current hemodynamic threshold for pulmonary hypertension itself.

The guideline explicitly prefers standard RVSP reporting over calculating mPAP, since RVSP comes directly from a single measured peak velocity, while the mPAP formulas above all rely on additional indirect calculations and assumptions that introduce more opportunity for error. mPAP reporting is reasonable specifically when RVSP estimation itself is limited by an inadequate TR signal.

Pulmonary Vascular Resistance

PVR describes the pulmonary circulation’s resistive afterload on the RV specifically — distinct from PASP alone, since pressure is the product of flow and resistance, and an elevated PASP can reflect a high-flow state just as easily as true elevated resistance. The Abbas formula estimates it noninvasively:

PVR (Wood units) = [(peak TR velocity ÷ RVOT VTI) × 10] + 0.16

Normal PVR is under 1.5 Wood units; PVR over 2.0 Wood units is abnormal and suggestive of PH. Small errors in either peak TR velocity or RVOT VTI meaningfully affect the result, and the formula becomes unreliable at very high PVR (>8 Wood units), since it was derived within a more typical clinical range. PVR is not recommended for routine use given these limitations, but calculating it can specifically help distinguish whether an elevated PASP reflects pulmonary vascular disease or a high-output/postcapillary cause instead.

A related, complementary principle worth knowing even without formally calculating PVR: RVOT VTI itself is a stroke-distance surrogate for cardiac output. A high stroke distance with only borderline PASP elevation (as can occur in high-flow states like sickle cell disease or end-stage liver disease) suggests normal PVR despite the elevated pressure; conversely, a very low stroke distance (VTI well below 17 cm) can signal markedly increased PVR even when PASP is only mildly elevated — a quick qualitative check before assuming pressure and resistance are moving together.

Pulmonary Capillary Wedge Pressure

Estimated from the mitral inflow relationship: PCWP = (1.24 × mitral E/e′) + 1.9, with a normal value under 12–15 mmHg. This is explicitly not recommended for routine reporting, since it’s largely redundant with the averaged or medial mitral E/e′ that’s already part of a standard diastolic assessment — and its accuracy is further limited in LVAD patients, left bundle branch block, paced rhythms, atrial arrhythmias, mitral prostheses, significant mitral annular calcification, and primary mitral valve disease.

Limitations of Doppler-Based Hemodynamic Techniques

Worth keeping in mind across every parameter above: Doppler measurements are angle-dependent, requiring alignment within about 20° and interrogation from multiple windows to capture the true highest velocity; both overgaining (which exponentially amplifies apparent pressure) and undergaining (which loses the signal entirely) distort results; and arrhythmia, valvular disease, and right heart adaptation itself can all affect accuracy. Definitive diagnosis and classification of pulmonary hypertension still requires invasive right heart catheterization — echocardiography’s role is screening, risk stratification, and longitudinal monitoring, not a standalone diagnostic substitute.

Special Topics: Fluid Challenge and Exercise Hemodynamics

Fluid Challenge

A fluid challenge stresses the pulmonary circulation and can help distinguish precapillary from postcapillary PH when the resting picture is ambiguous. Typically 250–500 mL of crystalloid is given over 15–30 minutes. A positive response — an increase in PCWP above 18 mmHg and/or an increase in mitral E/e′ above 12 — indicates elevated left atrial pressure and supports occult LV diastolic dysfunction as a postcapillary contributor. Further validation is still needed before this becomes a routine part of standard echocardiography, but it’s a genuinely useful provocative test where the diagnosis is unclear.

Exercise Hemodynamics and RV Functional Reserve

Assessing RV-pulmonary coupling under stress adds real diagnostic and prognostic information beyond resting measures, evaluating both symptoms (dyspnea, fatigue) and characteristic pre- versus postcapillary echocardiographic response patterns. Semirecumbent bicycle stress is the preferred method for this specific purpose, since it allows imaging during and at peak exertion — unlike treadmill exercise, where hemodynamics can normalize too quickly afterward to capture.

• An abnormal pulmonary vascular response to exercise is defined as a rest-to-stress RVSP increase of ≥20 mmHg and/or a peak RVSP ≥50 mmHg.
• A rest-to-stress mitral E/e′ above 12 suggests a postcapillary component; E/e′ ≥15 is associated with higher mortality risk, independent of ischemia or LV dysfunction.
• Worsening mitral or tricuspid regurgitation alongside a rising RVSP during exercise further supports a postcapillary phenotype.
• PASP itself is influenced by age and physical conditioning, so an isolated exercise PASP value needs to be read against these normal variations, not a single fixed cutoff, before being called abnormal.

Tricuspid Regurgitation: Two Mechanistically Distinct Entities

Functional TR — from adverse RV remodeling with genuine leaflet tethering — is the mechanism most often discussed, but atriofunctional TR (AFTR) is increasingly recognized as a mechanistically distinct entity worth actively distinguishing from it, not a minor subtype. See Tricuspid Regurgitation for the broader TR grading framework this builds on.

Feature	Functional TR (ventricular)	Atriofunctional TR
Primary driver	RV remodeling and dilation	RA enlargement and annular dilation alone
Leaflet tethering	Present — tethering height >8 mm or tenting area >1.6 cm² is significant	Absent — tenting height ≤10 mm
RV size	Dilated	RV midventricular dimension ≤38 mm (not dilated)
LV function	Variable	LVEF ≥50%
Typical association	RV pressure or volume overload	Long-standing atrial fibrillation, RA > LA
Prognosis	Worse	Better than functional TR

AFTR’s mechanism is specific: progressive RA dilation makes the tricuspid annulus more planar and circular, with disproportionately greater anteroposterior than mediolateral dilation — reducing leaflet coaptation (normally 5–10 mm) and producing malcoaptation, without the ventricular tethering that drives classic functional TR. Distinguishing the two mechanisms, and documenting which one is driving a given patient’s TR, is now considered part of a standardized report rather than an optional refinement — the RV sphericity index (short-axis ÷ long-axis diameter from the apical four-chamber view, normal 0.49 ± 0.11) and RV eccentricity index are supplementary tools for characterizing the ventricular contribution when present.

A Disease-Oriented Approach

Rather than applying one uniform set of cutoffs to every condition, current guidance recommends weighting RV parameters according to the specific disease being evaluated, since different parameters have different sensitivities depending on the underlying pathophysiology:

• Pulmonary hypertension — radial function (FAC) tends to be more representative of global RV function than longitudinal measures alone, since pressure overload affects the ventricle’s overall contraction pattern in a way a single basal longitudinal measurement can miss.
• Cardiac amyloidosis (a restrictive infiltrative process) — RV longitudinal function (TAPSE) is particularly well-suited here and has outperformed even RV ejection fraction by cardiac MRI as a prognostic marker in this specific condition.
• Arrhythmogenic RV cardiomyopathy — regional findings matter more than any global summary number: specific RV outflow tract dimensions, regional wall motion abnormalities (akinesia and dyskinesia specifically, not hypokinesia), and aneurysm formation are the diagnostic focus, which is why a measure that only reflects basal longitudinal function has poor sensitivity for this disease.

Clinical Applications

Common causes of RV enlargement or dysfunction, organized by mechanism:

• Pressure overload — pulmonary hypertension, pulmonary embolism, COPD, congenital lesions such as tetralogy of Fallot or pulmonic stenosis
• Volume overload — tricuspid regurgitation, atrial septal defect (see Atrial Septal Defect for the shunt physiology behind this), patent ductus arteriosus — see the Tricuspid Regurgitation tutorial for how functional TR itself develops from and contributes to adverse RV remodeling, and see Pulmonary Regurgitation for pulmonic valve disease’s own contribution to RV volume overload
• Myocardial disease — RV infarction (see the coronary supply discussion above for why the subcostal view matters here specifically), arrhythmogenic RV cardiomyopathy
• Systemic infiltrative disease — sarcoidosis, amyloidosis
• Post-surgical/interventional — post-lung transplant, after congenital heart defect repair (where TAPSE and S′ are both commonly, and often falsely, reduced regardless of true underlying function — a pitfall worth remembering)
• Pericardial disease — a large or hemodynamically significant pericardial effusion can compress the RV free wall directly, since it’s the lowest-pressure chamber for most of the cardiac cycle — RV diastolic collapse is one of the key signs of cardiac tamponade

Key disease-specific patterns:

• Pulmonary hypertension — RV dilation and hypertrophy, elevated TR velocity, abnormal septal motion (flattening, with an eccentricity index above 1.1 considered abnormal); see the PH phenotype table above for how the pattern differs by underlying WSPH group.
• Heart failure — RV function is a major independent determinant of prognosis in both HFrEF and HFpEF; reduced TAPSE, FAC, and S′ velocity alongside RV enlargement all carry prognostic weight
• Congenital heart disease — RV size, pressure, and function assessment is central to conditions like ASD, VSD (see Ventricular Septal Defect for RV pressure estimation from the VSD jet), tetralogy of Fallot, and Ebstein’s anomaly, with the expected RV shape and function pattern depending heavily on the specific defect — including cases like tricuspid atresia, where the RV is better described as a rudimentary outlet chamber lacking its inlet component entirely, rather than simply “small” — see Pediatric Transthoracic Echocardiography for the segmental approach used to systematically characterize this anatomy
• Arrhythmogenic RV cardiomyopathy — regional wall motion abnormalities and RV dilation, with tissue Doppler and strain imaging valuable for detecting the regional findings central to diagnosis